https://www.israelnationalnews.com/news/318325
An Israeli study published on Wednesday in the New England Journal of Medicine finds that a third dose (booster) of the Pfizer coronavirus vaccine reduces the risk of COVID-related death by 90 percent.
The study was conducted by the Clalit Health Services Health Maintenance Organization, together with the Maximizing Health Outcomes Research Lab at Sapir College in Sderot and the Faculty of Health Sciences at Ben-Gurion University of the Negev in Be’er Sheva.
The study, which was conducted on people aged 50 and older, followed up on clients from all HMOs who received the second dose of the vaccine at least five months earlier, and compared the fatality rates from COVID-19 among the group that received the booster shot to the group that did not.
The study was conducted during the Delta variant wave, between August 6, 2021 (a week after the booster shot was approved for adults in Israel) and September 29, 2021.
No comments :
Post a Comment
ANONYMOUS COMMENTS WILL NOT BE POSTED!
please use either your real name or a pseudonym.